Kewaunee Scientific Corporation
KEQU · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $119,563 | $157,774 | $90,386 | $184,670 |
| - Cash | $12,594 | $19,489 | $14,942 | $9,454 |
| + Debt | $17,669 | $18,337 | $50,155 | $55,788 |
| Enterprise Value | $124,638 | $156,622 | $125,599 | $231,004 |
| Revenue | $70,096 | $71,104 | $77,148 | $67,167 |
| % Growth | -1.4% | -7.8% | 14.9% | – |
| Gross Profit | $19,720 | $20,930 | $24,038 | $18,379 |
| % Margin | 28.1% | 29.4% | 31.2% | 27.4% |
| EBITDA | $6,094 | $6,527 | $9,887 | $3,975 |
| % Margin | 8.7% | 9.2% | 12.8% | 5.9% |
| Net Income | $2,445 | $3,093 | $4,850 | $1,354 |
| % Margin | 3.5% | 4.3% | 6.3% | 2% |
| EPS Diluted | 0.82 | 1.04 | 1.63 | 0.45 |
| % Growth | -21.2% | -36.2% | 262.2% | – |
| Operating Cash Flow | -$4,265 | $5,791 | $9,407 | -$2,266 |
| Capital Expenditures | -$1,570 | -$771 | -$516 | -$689 |
| Free Cash Flow | -$5,835 | $5,020 | $8,891 | -$2,955 |